Skip to the main content
The Crier

Contract for supply of Hib-Men C vaccine

Your saved contracts

What the buyer wrote

The provision of a vaccine to protect against Haemophilus influenzae type B (Hib) and meningitis C (MenC), to be used in the national childhood immunisation programme. The contracting authority estimates their requirement over the period of the contract to be up to 3 000 000 doses. Deliveries will be required over a period of 2 years. Previously advised the market that a contract will be awarded for the supply of haemophilus influenza type b, meningococcal C vaccine (Hib/Men c), which has been concluded. VEAT reference : 2019/S 187-454780

Bid for this and lost? There is a short window in which the decision can be questioned.

Awarded to

GlaxoSmithKline UK Ltdends (31 Dec 2022)

Details

What the buyer calls it
Contract for supply of Hib-Men C vaccine
How they are buying
Given to one supplier, no competitionNobody else was asked, and the buyer has to be able to justify that.
Type
goods
Work starts
1 Jan 2021
Work ends
31 Dec 2022

Who the buyer named

The buyer published a contact address on this notice.

livingwithcancer@dhsc.gov.uk